ProFunds Pharmaceuticals UltraSector Fund Service Class (PHPSX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
17.39
-0.92 (-5.02%)
May 6, 2025, 4:00 PM EDT
-10.77% (1Y)
| Fund Assets | 10.07M |
| Expense Ratio | 2.78% |
| Min. Investment | $5,000 |
| Turnover | n/a |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Dividend Growth | n/a |
| Payout Frequency | n/a |
| Ex-Dividend Date | n/a |
| Previous Close | 18.31 |
| YTD Return | -10.64% |
| 1-Year Return | -6.05% |
| 5-Year Return | 12.50% |
| 52-Week Low | n/a |
| 52-Week High | n/a |
| Beta (5Y) | 0.91 |
| Holdings | 55 |
| Inception Date | Jun 28, 2000 |
About PHPSX
The ProFunds Pharmaceuticals UltraSector Fund Service Class (PHPSX) seeks to measure the performance of certain companies in the pharmaceuticals sector of the U.S. equity market.
Category Trading--Leveraged Equity
Performance Rating Below Average
Risk Rating High
Stock Exchange NASDAQ
Ticker Symbol PHPSX
Share Class Service Class
Index S&P 500 TR
Performance
PHPSX had a total return of -6.05% in the past year, including dividends. Since the fund's inception, the average annual return has been 0.82%.
Other Share Classes
These are alternative share classes of the same fund, from the same provider.
| Symbol | Share Class | Expense Ratio |
|---|---|---|
| PHPIX | Investor Class | 1.78% |
Top 10 Holdings
36.30% of assets| Name | Symbol | Weight |
|---|---|---|
| SOCIETE' GENERALE C 4.2 , 2/03/2025 | n/a | 5.05% |
| HSBC SECURITIES (USA), INC. B 4.2 , 2/03/2025 | n/a | 4.62% |
| Intra-Cellular Therapies Inc. | ITCI | 4.41% |
| Royalty Pharma plc | RPRX | 3.66% |
| Corcept Therapeutics Incorporated | CORT | 3.25% |
| Axsome Therapeutics, Inc. | AXSM | 3.17% |
| Pfizer Inc. | PFE | 3.07% |
| Bristol-Myers Squibb Company | BMY | 3.04% |
| Johnson & Johnson | JNJ | 3.02% |
| Tarsus Pharmaceuticals, Inc. | TARS | 3.01% |